Clinical isolates of measles virus use CD46 as a cellular receptor

Journal of Virology

Volumn 74, Issue 9, 2000, Pages 3967-3974

  Manchester, Marianne ^a   Eto, Danelle S ^a   Valsamakis, Alexandra ^a,e   Liton, Paloma B ^b   Fernandez Muñoz, Rafael ^b   Rota, Paul A ^c   Bellini, William J ^c   Forthal, Donald N ^d   Oldstone, Michael B A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE COFACTOR PROTEIN;

ANIMAL CELL; ARTICLE; CELL SPECIFICITY; CONTROLLED STUDY; MEASLES; MEASLES VIRUS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STRAIN DIFFERENCE; VERO CELL; VIRUS PATHOGENESIS; VIRUS STRAIN;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD46; CERCOPITHECUS AETHIOPS; CHO CELLS; CRICETINAE; HEMAGGLUTININS, VIRAL; LYMPHOCYTES; MEASLES; MEASLES VIRUS; MEMBRANE GLYCOPROTEINS; MICE; RECEPTORS, VIRUS; VERO CELLS; VIRUS REPLICATION;

EID: 0033995573     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.9.3967-3974.2000     Document Type: Article

References (59)

1. Adams, E. M., M. C. Brown, M. Nunge, M. Krych, and J. P. Atkinson. 1991. Contribution of the repeating domains of membrane cofactor protein (MCP; CD46) of the complement system to ligand binding and cofactor activity. J. Immunol. 147:3005-3011.
2. Albrecht, P., F. A. Ennis, E. J. Saltzman, and S. Krugman. 1977. Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure. J. Pediatr. 91:775-778.
3. Anonymous. 1998. AIDS in Africa. World Health Forum 19:214.
4. Anonymous. 1989. Measles, United States, 1st 26 weeks 1989. Morbid. Mortal. Weekly Rep. 38:863-871.
5. Anonymous. 1989. Measles-United States. Morbid. Mortal. Weekly Rep. 38: 601-605.
6. Anonymous. 1995. Measles. Morbid. Mortal. Weekly Rep. 45:305-307.
7. Bartz, R., R. Firsching, B. Rima, V. ter Meulen, and J. Schneider-Schaulies. 1998. Differential receptor usage by measles virus strains. J. Gen. Virol. 79: 1015-1025.
8. Bauer, P. H., R. T. Bronson, S. C. Fung, R. Freund, T. Stehle, S. C. Harrison, and T. L. Benjamin. 1995. Genetic and structural analysis of a virulence determinant in polyomavirus VP1. J. Virol. 69:7925-7931.
9. Bloom, B. R. 1989. Vaccines for the third world. Nature 342:115-120.
10. Buchholz, C. J., D. Koller, P. Devaux, C. Mumenthaler, J. Schneider-Schaulies, W. Braun, D. Gerlier, and R. Cattaneo. 1997. Mapping of the primary binding site of measles virus to its receptor CD46. J. Biol. Chem. 272:22072-22079.
11. Buckland, R., and T. F. Wild. 1997. Is CD46 the cellular receptor for measles virus? Virus Res. 48:1-9.
12. Burnet, F. M. 1968. Measles as an index of immunological function. Lancet ii:610-613.
13. Cho, S.-W., T. J. Oglesby, B.-L. Hsi, E. M. Adams, and J. P. Atkinson. 1991. Characterization of three monoclonal antibodies to membrane cofactor protein (MCP) of the complement system and quantitation of MCP by radioassay. Clin. Exp. Immunol. 83:257-261.
14. Clements, C. J., and F. T. Cutts. 1995. The epidemiology of measles: thirty years of vaccination. Curr. Top. Microbiol. Immunol. 191:13-33.
15. Devaux, P., B. Loveland, D. Christiansen, J. Milland, and D. Gerlier. 1996. Interactions between the ectodomains of haemagglutinin and CD46 as a primary step in measles virus entry. J. Gen. Virol. 77:1477-1481.
16. Dorig, R., A. Marcel, A. Chopra, and C. D. Richardson. 1993. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75: 295-305.
17. Firsching, R., C. J. Buchholz, U. Schneider, R. Cattaneo, V. ter Meulen, and J. Schneider-Schaulies. 1999. Measles virus spread by cell-cell contacts: uncoupling of contact-mediated receptor (CD46) downregulation from virus uptake. J. Virol. 73:5265-5273.
18. Forthal, D. N., S. Aarnaes, J. Blanding, L. de la Maza, and J. G. Tilles. 1992. Degree and length of viremia in adults with measles. J. Infect. Dis. 166: 421-424.
19. Gellin, B. G., and S. L. Katz. 1994. Measles: state of the art and future directions. J. Infect. Dis. 170(Suppl. 1):3-14.
20. Griffin, D. E., and W. J. Bellini. 1996. Measles virus, p. 1267-1312. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Virology, vol. 3. Lippincott-Raven, Philadelphia, Pa.
21. Horvat, B., P. Rivailler, G. Varior-Krishnan, A. Cardoso, D. Gerlier, and C. Rabourdin-Combe. 1996. Trarsgenic mice expressing human measles virus (MV) receptor provide cells exhibiting different permissivities to MV infection. J. Virol. 70:6673-6681.
22. Hourcade, D., V. M. Holers, and J. P. Atkinson. 1989. The regulators of complement activation (RCA) gene cluster. Adv. Immunol. 6:381-416.
23. Hsi, B.-L., C.-J. G. Yeh, P. Penichel, M. Samson, and C. Grivaux. 1988. Monoclonal antibody GB24 recognizes a trophoblast-lymphocyte cross-reactive antigen. Am. J. Reprod. Immunol. Microbiol. 18:21-27.
24. Hsu, E. C., R. E. Dorig, F. Sarangi, A. Marcil, C. Iorio, and C. D. Richardson. 1997. Artificial mutations and natural variations in the CD46 molecules from human and monkey cells define regions important for measles virus binding. J. Virol. 71:6144-6154.
25. Hsu, E. C., F. Sarangi, C. Iorio, M. S. Sidhu, S. A. Udem, D. L. Dillehay, W. Xu, P. A. Rota, W. J. Bellini, and C. D. Richardson. 1998. A single amino acid change in the hemagglutinin protein of measles virus determines its ability to bind CD46 and reveals another receptor on marmoset B cells. J. Virol. 72:2905-2916.
26. Hwang, S. S., T. J. Boyle, H. K. Lyerly, and B. R. Cullen. 1992. Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1. Science 257:535-537.
27. Ivey-Hoyle, M., J. S. Culp, M. A. Chaikin, B. D. Hellmig, T. J. Matthews, R. W. Sweet, and M. Rosenberg. 1991. Envelope glycoproteins from biologically diverse isolates of immunodeficiency viruses have widely different affinities for CD4. Proc. Natl. Acad. Sci. USA 88:512-516.
28. Iwata, K., T. Seya, Y. Yanagi, J. Pesando, P. Johnson, M. Okabe, S. Ueda, H. Ariga, and S. Nagasawa. 1995. Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46. J. Biol. Chem. 270:15148-15152.
29. Johnston, I., V. ter Meulen, J. Schneider-Schaulies, and S. Schneider-Schaulies. 1999. A recombinant measles vaccine virus expressing wild-type glycoproteins: consequences for viral spread and cell tropism. J. Virol. 73: 6903-6915.
30. Karber, G. 1931. Beitrag zur kollektiven Behandlung pharmakologischer Reihenverusche. Arch. Exp. Pathol. Pharmakol. 162:480-483.
31. Katz, S. L., and B. G. Gellin. 1994. Measles vaccine: do we need new vaccines or new programs? Science 265:1391-1392.
32. Keppler, O. T., M. E. Peter, S. Hinderlich, G. Moldenhauer, P. Stehling, I. Schmitz, R. Schwartz-Albiez, W. Reutter, and M. Pawlita. 1999. Differential sialylation of cell surface glycoconjugates in a human B lymphoma cell line regulates susceptibility for CD95 (APO-1/Fas)-mediated apoptosis and for infection by a lymphotropic virus. Glycobiology 9:557-569.
33. Klimstra, W. B., K. D. Ryman, and R, E. Johnston. 1998. Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J. Virol. 72:7357-7366.
34. Kobune, F., H. Sakata, and G. Sugiura. 1990. Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J. Virol. 64:700-705.
35. Lecouturier, V., J. Fayolle, M. Caballero, J. Carabana, M. Celma, R. Fernandez-Munoz, T. Wild, and R. Buckland. 1996. Identification of two amino acids in the hemagglutinin glycoprotein of measles virus (MV) that govern hemadsorption, HeLa cell fusion, and CD46 downregulation: phenotypic markers that differentiate vaccine and wild-tvpe MV strains. J. Virol. 70: 4200-4204.
36. Liszewski, M. K., and J. P. Atkinson. 1992. Membrane cofactor protein. Curr. Top. Microbiol. Immunol. 178:45-60.
37. Liszewski, M. K., T. W. Post, and J. P. Atkinson. 1991. Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu. Rev. Immunol. 9:431-455.
38. Malvoisin, E., and T. F. Wild. 1993. Measles virus glycoproteins: studies on the structure and interaction of the hemagglutinin and fusion proteins. J. Gen. Virol. 74:2365-2372.
39. Manchester, M., M. K. Liszewski, J. P. Atkinson, and M. B. A. Oldstone. 1994. Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus. Proc. Natl. Acad. Sci. USA 91:2161-2165.
40. Manchester, M., A. Valsamakis, R. Kaufman, M. K. Liszewski, J. P. Atkinson, D. M. Lublin, and M. B. A. Oldstone. 1995. Measles virus and C3 binding sites are distinct on membrane cofactor protein (MCP; CD46). Proc. Natl. Acad. Sci. USA 92:2303-2307.
41. McChesney, M., C. Miller, P. Rota, Y. Zhu, L. Antipa, N. Lerche, R. Ahmed, and W. Bellini. 1997. Experimental measles. I. Pathogenesis in the normal and the immunized host. Virology 233:74-84.
42. McLean, A. 1995. After the honeymoon in measles control. Lancet 345:272.
43. Naniche, D., G. Varior-Krishnan, F. Cervino, T. F. Wild, B. Rossi, C. Rabourdin-Combe, and D. Gerlier. 1993. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 67:6025-6032.
44. Naniche, D., T. F. Wild, C. Rabourdin-Combe, and D. Gerlier. 1993. A monoclonal antibody recognized a human cell surface glycoprotein involved in measles virus binding. J. Gen. Virol. 73:2617-2624.
45. Norrby, E., and M. Oxman. 1990. Measles virus, p. 1013-1045. In B. N. Fields and D. M. Knipe (ed.), Virology. Raven, New York, N.Y.
46. Nussbaum, O., C. C. Broder, B. Moss, L. Bar-Lev Stern, S. Rozenblatt, and E. A. Berger. 1995. Functional and structural interaction between measles virus hemagglutinin and CD46. J. Virol. 69:3341-3349.
47. Oldstone, M. B. A., H. Lewicki, D. Thomas, A. Tishon, S. Dales, J. Patterson, M. Manchester, D. Homann, D. Naniche, and A. Holz. 1999. Measles virus infection in a transgenic model: virus-induced central nervous system disease and immunosuppression. Cell 98:629-640.
48. Patterson, J. B., F. Scheiflinger, M. Manchester, T. Yilma, and M. B. A. Oldstone. 1999. Structural and functional studies of the measles virus hemagglutinin: identification of a novel site required for CD46 interaction. Virology 256:142-151.
49. Rall, G. F., M. Manchester, L. R. Daniels, E. Callahan, A. Belman, and M. B. A. Oldstone. 1997. A transgenic mouse model for measles virus infection of the brain. Proc. Natl. Acad. Sci. USA 94:4659-4663.
50. Rima, B. K., J. A. P. Earle, K. Baczko, V. terMeulen, U. G. Liebert, C. Carstens, J. Carabana, M. Caballero, M. L. Celma, and R. Fernandez-Munoz. 1997. Sequence divergence of measles virus haemagglutinin during natural evolution and adaptation to cell culture. J. Gen. Virol. 78:97-106.
51. Rima, B. K., J. A. P. Earle, R. P. Yeo, L. Herlihy, K. Baczko, V. ter Meulen, J. Carabana, M. Caballero, M. L. Celma, and R. Fernandez-Munoz. 1995. Temporal and geographical distribution of measles virus genotypes. J. Gen. Virol. 76:5773-5783.
52. Rota, J. S., K. B. Hummel, P. A. Rota, and W. J. Bellini. 1992. Genetic variability of the glycoprotein genes of current wild-type measles isolates. Virology 188:135-142.
53. Schneider-Schaulies, J., J.-J. Schnorr, U. Brinckmann, L. M. Dunster, K. Baczko, S. Schneider-Schaulies, and V. ter Meulen. 1995. Receptor usage and differential downregulation of CD46 by measles virus wild type and vaccine strains. Proc. Natl. Acad. Sci. USA 92:3943-3947.
54. Schrag, S. J., P. A. Rota, and W. J. Bellini. 1999. Spontaneous mutation rate of measles virus: direct estimation based on mutations conferring monoclonal antibody resistance. J. Virol. 73:51-54.
55. Seya, T., J. Turner, and J. P. Atkinson. 1986. Purification and characterization of a membrane protein (gp45-70) which is a cofactor for cleavage of C3b and C4b. J. Exp. Med. 163:837.
56. Takeda, M., A. Kato, F. Kobune, H. Sakata, T. Li, T. Shioda, Y. Sakai, M. Asakawa, and Y. Nagai. 1998. Measles virus attenuation associated with transcriptional impediment and a few amino acid changes in the polymerase and accessory proteins. J. Virol. 72:8690-8696.
57. Wild, T. F., E. Malvoisin, and R. Buckland. 1991. Measles virus: both the hemagglutinin and fusion glycoproteins are required for fusion. J. Gen. Virol. 72:439-442.
58. Willey, R. L., T. S. Theodore, and M. A. Martin. 1994. Amino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope. J. Virol. 69:4409-4419.
59. Yanagi, Y., H. Hu, T. Seya, and H. Yoshikura. 1994. Measles virus infects mouse fibroblast cell lines, but its multiplication is severely restricted in the absence of CD46. Arch. Virol. 138:39-53.